What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
1. Depression is an illness.Depression is an illness in the same way that diabetes and high blood pressure are illnesses. It's not just... Read more »
One of the first steps in giving support to someone with depression is to ensure they receive professional help. This is a big step and one... Read more »
One of the interesting things about depression is how little we know about thought processes before, during and after depression. There's... Read more »
Today is Sunday and I will be meeting a friend for coffee and a chat. We both lead very busy lives as parents and so it is a big deal to... Read more »
In a previous post we explored the possible reasons for the dramatic increase in antidepressant use over the past two decades. One theory... Read more »
According to Israeli researchers, depression may harm the bones as well as the mind. A meta-analysis of 23 studies on 2,327 people found that people... Read more »
An analysis of health data on more than 2 million people from 80 countries has found a remarkably consistent pattern about depression. In all 80... Read more »
Results from an analysis of clinical trial data for nearly 1,300 patients with Parkinson's disease has found that pramipexole (Mirapexin/Sifrol) may... Read more »
According to a study published in the April 8, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology, people who... Read more »
Recently released study data give women with depression yet another reason to work to minimize risks for osteoporosis. The study showed that... Read more »